[
    [
        {
            "time": "",
            "original_text": "葛兰勇进，高瓴撤退，CXO 困境下的“旗手”与“叛徒”",
            "features": {
                "keywords": [
                    "葛兰",
                    "高瓴",
                    "CXO",
                    "困境",
                    "旗手",
                    "叛徒"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "葛兰勇进，高瓴撤退，CXO 困境下的“旗手”与“叛徒”",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]